86 related articles for article (PubMed ID: 1804593)
21. Clostridium perfringens alpha-toxin and NetB toxin antibodies and their possible role in protection against necrotic enteritis and gangrenous dermatitis in broiler chickens.
Lee KW; Lillehoj HS; Park MS; Jang SI; Ritter GD; Hong YH; Jeong W; Jeoung HY; An DJ; Lillehoj EP
Avian Dis; 2012 Mar; 56(1):230-3. PubMed ID: 22545552
[TBL] [Abstract][Full Text] [Related]
22. Clostridium perfringens beta toxin DNA prime-protein boost elicits enhanced protective immune response in mice.
Solanki AK; Bhatia B; Kaushik H; Deshmukh SK; Dixit A; Garg LC
Appl Microbiol Biotechnol; 2017 Jul; 101(14):5699-5708. PubMed ID: 28523396
[TBL] [Abstract][Full Text] [Related]
23. The standardization of Cl. perfringens antigens and antisera.
Jansen BC
Dev Biol Stand; 1976; 32():35-44. PubMed ID: 187510
[TBL] [Abstract][Full Text] [Related]
24. Plasmodium berghei: characterization of antigens and their role in inducing immunity to infection.
Grothaus GD; Packer BJ; Castilla MM; Muller MT; Kreier JP
J Parasitol; 1984 Dec; 70(6):849-58. PubMed ID: 6396392
[TBL] [Abstract][Full Text] [Related]
25. Production and standardization of polyvalent Clostridium perfringens vaccine in Iran.
Ardehali M; Darakhshan H
Dev Biol Stand; 1976; 32():31-4. PubMed ID: 187509
[TBL] [Abstract][Full Text] [Related]
26. FIFTH INTERNATIONAL STANDARD FOR GAS-GANGRENE ANTITOXIN (PERFRINGENS) (CLOSTRIDIUM WELCHII TYPE A ANTITOXIN).
EVANS DG; PERKINS FT
Bull World Health Organ; 1963; 29(6):729-35. PubMed ID: 14107745
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.
Moreira GM; Salvarani FM; da Cunha CE; Mendonça M; Moreira ÂN; Gonçalves LA; Pires PS; Lobato FC; Conceição FR
Sci Rep; 2016 Mar; 6():22816. PubMed ID: 27004612
[TBL] [Abstract][Full Text] [Related]
28. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
[TBL] [Abstract][Full Text] [Related]
29. Development and application of an oral challenge mouse model for studying Clostridium perfringens type D infection.
Fernandez-Miyakawa ME; Sayeed S; Fisher DJ; Poon R; Adams V; Rood JI; McClane BA; Saputo J; Uzal FA
Infect Immun; 2007 Sep; 75(9):4282-8. PubMed ID: 17562765
[TBL] [Abstract][Full Text] [Related]
30. [Protective properties of theta-hemolysin obtained by affinity chromatography].
Efimova MG; Blagoveshchenskiĭ VA; Khatuntseva BV
Zh Mikrobiol Epidemiol Immunobiol; 1982 Dec; (12):87-92. PubMed ID: 6297191
[TBL] [Abstract][Full Text] [Related]
31. The alpha antitoxin content of the international reference preparations of Clostridium welchii types B and D antitoxins.
SKULBERG A; VAN HEYNINGEN WE
Bull World Health Organ; 1956; 14(3):557-66. PubMed ID: 13342930
[TBL] [Abstract][Full Text] [Related]
32. Experimental studies on serum treatment and vaccination against Cl. perfringens type C infection in piglets.
Hogh P
Dev Biol Stand; 1976; 32():69-76. PubMed ID: 187513
[TBL] [Abstract][Full Text] [Related]
33. Immunization of broiler chickens against Clostridium perfringens-induced necrotic enteritis.
Kulkarni RR; Parreira VR; Sharif S; Prescott JF
Clin Vaccine Immunol; 2007 Sep; 14(9):1070-7. PubMed ID: 17634510
[TBL] [Abstract][Full Text] [Related]
34. Refractoriness of rabbit towards Clostridium perfringens type A enterotoxin.
Chakrabarty AK; Narayan KG
Indian J Exp Biol; 1978 Mar; 16(3):402-3. PubMed ID: 210117
[No Abstract] [Full Text] [Related]
35. An international survey of clostridial sera and vaccines.
Davidson I
Dev Biol Stand; 1976; 32():3-14. PubMed ID: 187508
[TBL] [Abstract][Full Text] [Related]
36. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
[TBL] [Abstract][Full Text] [Related]
37. Generation and characterization of recombinant bivalent fusion protein r-Cpib for immunotherapy against Clostridium perfringens beta and iota toxemia.
Das S; Majumder S; Kingston JJ; Batra HV
Mol Immunol; 2016 Feb; 70():140-8. PubMed ID: 26774054
[TBL] [Abstract][Full Text] [Related]
38. Solid-phase radioimmunoassays for quantitative antibody determination of bacterial exotoxins. Measurement of Clostridium perfringens type D epsilon antitoxin.
Bernáth S
Dev Biol Stand; 1976; 32():77-83. PubMed ID: 187514
[TBL] [Abstract][Full Text] [Related]
39. Immunization of broiler chickens against Clostridium perfringens-induced necrotic enteritis using purified recombinant immunogenic proteins.
Jiang Y; Kulkarni RR; Parreira VR; Prescott JF
Avian Dis; 2009 Sep; 53(3):409-15. PubMed ID: 19848081
[TBL] [Abstract][Full Text] [Related]
40. On the in vitro neutralization test of Clostridium perfringens type A toxin.
Shemanova GF; Vlasova EV; Postnikova TM
J Hyg Epidemiol Microbiol Immunol; 1988; 32(2):219-26. PubMed ID: 2900852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
